Very common. Many trials these days have these "open label extensions". Travere's did. I'm sure your experts will back this up.
Ann: First patient enters into Open Label Extension study, page-44
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $214.7M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 41.0¢ | 38.5¢ | $1.104M | 2.784M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5501 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 7500 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |